0
0
0
0
1
2
3
$0
Is Veeva Systems solid or fragile? The Finex Financial Health Scanner reads VEEV's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $3.2B |
|---|---|
| Net income | $908.9M |
| Operating margin | 28.7% |
| Net margin | 28.4% |
| Cash and investments | $6.6B |
| Total debt | $151.7M |
| Free cash flow | $1.3B |
| Revenue growth (1 year) | 16.3% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.